BRITTANY MOSLEY: Open Payments
NPI 1811452709 · DEFUNIAK SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 29 payments from 13 companies in 2025. Trend: 2023 $192 · 2024 $695 · 2025 $545
Food & beverage: $545
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $114 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| ABBVIE INC. | 5 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Lilly USA, LLC | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Corcept Therapeutics | 1 | $19 |
Products named: VRAYLAR, FARXIGA, AIRSUPRA, XIFAXAN, ZEPBOUND, UBRELVY, FANAPT, Kerendia.
Industry payments across FL — which companies pay providers there.
